A handheld device for intra-cavity and ex vivo fluorescence imaging of breast conserving surgery margins with 5-aminolevulinic acid.
Christopher GibsonShirley C WangArcturus PhoonNayana Thalanki AnanthaKathryn Ottolino-PerryStephen PetropoulosZuha QureshiVasanth SubramanianAnam ShahidCristiana O'BrienSteven CarconeSuzanne ChungTeresa TsuiViktor SonMayleen SukhramFannong MengSusan J DoneAlexandra M EassonTulin CilMichael ReedijkWey L LeongRalph S DaCostaPublished in: BMC biomedical engineering (2024)
ClinicalTrials.gov Identifier: NCT01837225 (Trial start date is September 2010. It was registered to ClinicalTrials.gov retrospectively on April 23, 2013, then later updated on April 9, 2020, to reflect the introduction of the new imaging device.).
Keyphrases
- fluorescence imaging
- photodynamic therapy
- minimally invasive
- coronary artery bypass
- study protocol
- high resolution
- clinical trial
- phase iii
- phase ii
- neoadjuvant chemotherapy
- randomized controlled trial
- squamous cell carcinoma
- mass spectrometry
- percutaneous coronary intervention
- acute coronary syndrome
- coronary artery disease
- open label
- locally advanced
- rectal cancer